Shams Y-Hassan Selected Research

Takotsubo Cardiomyopathy

11/2021	Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study.
6/2020	Autonomic neurocardiogenic syndrome is stonewalled by the universal definition of myocardial infarction.
5/2020	Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.
12/2019	A case report: 'happy heart' syndrome in a patient treated with atomoxetine for attention deficit hyperactivity disorder.
10/2019	Plasma Epinephrine Level and its Causal Link to Takotsubo Syndrome Revisited: Critical Review with a Diverse Conclusion.
1/2018	Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?
1/2018	Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.
3/2017	Serotonin norepinephrine re-uptake inhibitor (SNRI)-, selective norepinephrine reuptake inhibitor (S-NRI)-, and exogenously administered norepinephrine-induced takotsubo syndrome: Analysis of published cases.
2/2017	Contemporary review on the pathogenesis of takotsubo syndrome: The heart shedding tears: Norepinephrine churn and foam at the cardiac sympathetic nerve terminals.
10/2016	Clinical features and outcome of epinephrine-induced takotsubo syndrome: Analysis of 33 published cases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shams Y-Hassan Research Topics

Disease

16	Takotsubo Cardiomyopathy 11/2021 - 01/2011
5	Myocardial Infarction 01/2022 - 01/2011
3	MINOCA 01/2022 - 01/2018
3	Pheochromocytoma 11/2021 - 12/2019
3	Left Ventricular Dysfunction 05/2020 - 01/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2019
2	Muscle Cramp (Cramp) 06/2020 - 12/2018
2	Edema (Dropsy) 12/2018 - 02/2017
2	Myocardial Stunning (Stunned Myocardium) 02/2017 - 11/2016
2	Spasm (Spasms) 01/2014 - 01/2011
1	Thrombophilia 01/2022
1	Thrombosis (Thrombus) 06/2021
1	Hypertension (High Blood Pressure) 07/2020
1	Neoplasms (Cancer) 07/2020
1	Ischemia 06/2020
1	Paraganglioma (Paragangliomas) 05/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2019
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Myocarditis (Carditis) 02/2017
1	Necrosis 02/2017
1	Sepsis (Septicemia) 09/2014
1	Heart Failure 06/2014
1	Left Ventricular Outflow Obstruction 01/2014
1	Cardiotoxicity 01/2014
1	Atrial Fibrillation 03/2013
1	Adenocarcinoma 01/2013
1	Cardiogenic Shock 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Acute Coronary Syndrome 01/2011
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2011

Drug/Important Bio-Agent (IBA)

9	CatecholaminesIBA 11/2021 - 01/2014
5	Epinephrine (Adrenaline)FDA LinkGeneric 06/2020 - 10/2016
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2019 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2019
2	Serotonin (5 Hydroxytryptamine)IBA 12/2019 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2011
1	Immunoglobulin A (IgA)IBA 01/2022
1	Protein CIBA 01/2022
1	Cardiolipins (Cardiolipin)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Protein C InhibitorIBA 01/2022
1	Antiphospholipid AntibodiesIBA 01/2022
1	MetanephrineIBA 11/2021
1	NormetanephrineIBA 11/2021
1	TroponinIBA 06/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2020
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 12/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Agouti-Related ProteinIBA 01/2019
1	ChemokinesIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	P-SelectinIBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	LigandsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	ReninIBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	Carvedilol (Coreg)FDA LinkGeneric 01/2018
1	Labetalol (Normodyne)FDA LinkGeneric 01/2018
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2018
1	Propranolol (Inderal)FDA LinkGeneric 01/2018
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 03/2017
1	SodiumIBA 03/2013
1	Adenosine (Adenocard)FDA LinkGeneric 03/2013
1	Thiopental (Pentothal)FDA Link 03/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2013
1	ProdrugsIBA 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2011
1	Coloring Agents (Dyes)IBA 01/2011

Therapy/Procedure

2	Therapeutics 07/2020 - 01/2013
2	Sympathectomy (Sympathectomies) 02/2017 - 06/2014
1	Stents 06/2021
1	Renal Dialysis (Hemodialysis) 11/2016
1	Electric Countershock (Cardioversion) 03/2013
1	Colectomy 01/2013